Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Corvus Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +1 vs. Q1 2021
- Shares held
- 23.7M
- +3.28M (+16.1%) vs. Q1 2021
- Total value
- $63.2M
- +$396.0K (+0.6%) vs. Q1 2021
- New holders
- 4
- 13 more added
- Sold out
- 3
- 17 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 92 | $0 | 0.00% | −9,844−99.1% | Reduced |
| Simplex Trading, LLC | 199 | $0 | 0.00% | −5,687−96.6% | Reduced |
| Barclays PLC | 4 | $0 | 0.00% | −533−99.3% | Reduced |
| Wells Fargo & Company | 165 | $0 | 0.00% | +1+0.6% | Added |
| Citigroup Inc | 27 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $0 | 0.00% | +20 | New |
| Panagora Asset Management Inc | 424 | $1.00K | 0.00% | −22−4.9% | Reduced |
| Meeder Asset Management Inc | 645 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,100 | $3.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 2,500 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,000 | $8.00K | 0.00% | +2,000+200.0% | Added |
| Whittier Trust Co of Nevada Inc | 4,200 | $11.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 7,076 | $19.0K | 0.00% | −2,875−28.9% | Reduced |
| Tower Research Capital LLC (TRC) | 7,654 | $20.0K | 0.00% | −35,132−82.1% | Reduced |
| Mercer Global Advisors Inc | 10,500 | $28.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,500 | $28.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 11,200 | $30.0K | 0.00% | 00.0% | Unchanged |
| Windsor Creek Advisors, LLC | 14,786 | $39.0K | 0.01% | 00.0% | Unchanged |
| Algert Global LLC | 19,737 | $53.0K | 0.02% | −23,120−53.9% | Reduced |
| Hikari Power Ltd | 19,959 | $53.0K | 0.01% | 00.0% | Unchanged |
| Truist Financial Corp | 21,000 | $56.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 25,583 | $68.0K | 0.00% | −5,221−16.9% | Reduced |
| Natixis | 27,900 | $74.0K | 0.00% | +11,400+69.1% | Added |
| Citadel Advisors LLC | 29,278 | $78.0K | 0.00% | −34,993−54.4% | Reduced |
| State Street Corp | 29,600 | $79.0K | 0.00% | +29,600 | New |
| Susquehanna International Group, LLP | 35,706 | $95.0K | 0.00% | −55,532−60.9% | Reduced |
| Morgan Stanley | 37,124 | $99.0K | 0.00% | −129−0.3% | Reduced |
| Verition Fund Management LLC | 41,788 | $112.0K | 0.00% | +41,788 | New |
| Stonepine Capital Management, LLC | 46,886 | $125.0K | 0.07% | −269,393−85.2% | Reduced |
| Acadian Asset Management LLC | 50,979 | $136.0K | 0.00% | +30,043+143.5% | Added |
| Laurion Capital Management LP | 59,150 | $158.0K | 0.00% | −222,982−79.0% | Reduced |
| Northern Trust Corp | 59,262 | $158.0K | 0.00% | +21,384+56.5% | Added |
| Ikarian Capital, LLC | 100,000 | $267.0K | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 130,928 | $350.0K | 0.00% | +53,260+68.6% | Added |
| Millennium Management LLC | 131,435 | $351.0K | 0.00% | +32,339+32.6% | Added |
| Geode Capital Management, LLC | 189,541 | $506.0K | 0.00% | +40,707+27.4% | Added |
| Bridgeway Capital Management, LLC | 209,300 | $559.0K | 0.01% | +5,000+2.4% | Added |
| Telemetry Investments, L.L.C. | 263,975 | $705.0K | 0.98% | +14,969+6.0% | Added |
| Two Sigma Advisers, LP | 288,300 | $770.0K | 0.00% | −3,700−1.3% | Reduced |
| Two Sigma Investments, LP | 309,653 | $827.0K | 0.00% | −39,103−11.2% | Reduced |
| Dimensional Fund Advisors LP | 395,829 | $1.06M | 0.00% | −20,820−5.0% | Reduced |
| Renaissance Technologies LLC | 658,070 | $1.76M | 0.00% | −5,400−0.8% | Reduced |
| CHI Advisors LLC | 719,132 | $1.92M | 0.45% | +40,000+5.9% | Added |
| Vanguard Group Inc | 1,109,218 | $2.96M | 0.00% | +109,099+10.9% | Added |
| Adams Street Partners LLC | 3,275,616 | $8.75M | 1.82% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,579,377 | $9.56M | 0.36% | +3,579,377 | New |
| BVF Inc | 3,678,626 | $9.82M | 0.37% | +449,200+13.9% | Added |
| OrbiMed Advisors LLC | 8,053,298 | $21.5M | 0.22% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −336,748−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −95,613−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,830−100.0% | Sold out |